Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2023-03-31 00:00:00 ET · period of report 2023-03-29 · accession 0001415889-23-005668 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-31 | 2023-03-29 | HRMY | Kapadia Sandip | CFO | F - Tax | $33.36 | -15.4K | 14.6K | -51% | -$514.2K |
| D | 2023-03-31 | 2023-03-29 | HRMY | Kapadia Sandip | CFO | M - OptEx | $0.00 | +30.0K | 30.0K | New | $0 |
| D | 2023-03-31 | 2023-03-29 | HRMY | Kapadia Sandip | CFO | M - OptEx | $0.00 | -30.0K | 30.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-29 | F | D | 15,414 | $33.36 | 14,586 | D | — | — | (F1) Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
| 2 | Common | Common Stock | 2023-03-29 | M | A | 30,000 | $0.00 | 30,000 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-03-29 | M | D | 30,000 | $0.00 | 30,000 | D | — · — to — | 30,000 Common Stock | (F2) This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023. 25% of the underlying shares are scheduled to vest on each of March 29, 2024 and March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. |